Synthace Stock

Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.

Sign up today and learn more about Synthace Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Synthace Stock

Synthace is a R&D cloud platform. Synthace aims to automate experimentation and insight sharing for scientists to share, view, and access progress with cures and therapeutics in one place.

Synthace was founded in 2011 and is headquartered in London, White City. Notable investors include Horizons Ventures, Sofinnova Partners, Amadeus Capital Partners, and Luminous Ventures.

Funding History

August 2013$1.5M
January 2015$2.9M
September 2017$10.5M
June 2018$3.1M
December 2018$25.4M
November 2021$6.8M
November 2021$26.8M



Guy Levy-Yurista

Co-founder & Chief Scientific Officer

Markus Gershater

Chief Product Officer

Mathieu Ayel


finsmes - Sep, 24 2013

FinSMEs | Synthace Raises 1.3M

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: